Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75,090 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study.
Yan D, Niu S, Hu D, Dong W, Sun Y, Wang Q, Wang S, Gu Q, Liu G, Wang J, Chen L, Lv J, Zheng Q, Song H, Fang Y. Yan D, et al. Among authors: wang j, wang s, wang q. Expert Opin Investig Drugs. 2023 Feb;32(2):161-170. doi: 10.1080/13543784.2023.2178894. Epub 2023 Feb 20. Expert Opin Investig Drugs. 2023. PMID: 36755413 Clinical Trial.
Pharmacokinetic Interactions and Tolerability of Rosuvastatin and Ezetimibe: A Randomized, Phase 1, Crossover Study in Healthy Chinese Participants.
Wang L, Luan Y, Jia C, Xie X, Zhang Z, Xie X, Wang Q, Hu C, Xie F, Abdel-Moneim M, Hovsepian L, Zhao Z, Yang N, Hou J. Wang L, et al. Among authors: wang q. Eur J Drug Metab Pharmacokinet. 2023 Jan;48(1):51-62. doi: 10.1007/s13318-022-00798-1. Epub 2022 Nov 27. Eur J Drug Metab Pharmacokinet. 2023. PMID: 36437383 Free PMC article. Clinical Trial.
A Bioequivalence Study of Ezetimibe/Rosuvastatin Fixed Dose Combination (10 mg/10 mg) Versus the Individual Formulations Taken Concomitantly.
Di Y, Wang Z, Jia C, Xie X, Yang S, Wang W, Xie X, Wang Q, Hu C, Xie F, Abdel-Moneim M, Hovsepian L, Wu Y, Yang N, Hou J. Di Y, et al. Among authors: wang w, wang z, wang q. Adv Ther. 2023 May;40(5):2205-2216. doi: 10.1007/s12325-023-02439-8. Epub 2023 Mar 10. Adv Ther. 2023. PMID: 36897521 Free PMC article. Clinical Trial.
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate-To-Severe Disease Activity - A Multicenter Cohort Study of Treatment Strategies and Outcomes.
Deng Y, Qiao L, Li H, Yu C, Jin S, Wang J, Zou Q, Wu L, Duan X, Xu J, Mo H, Jiang Z, Jiang N, Wang Y, Zeng X, Li M, Wang Q, Tian X; CREDIT Co‐authors. Deng Y, et al. Among authors: wang q. Int J Rheum Dis. 2025 Jan;28(1):e70066. doi: 10.1111/1756-185X.70066. Int J Rheum Dis. 2025. PMID: 39825583
75,090 results
You have reached the last available page of results. Please see the User Guide for more information.